✦ LIBER ✦

PP-7-5 phase II study of paclitaxel (P) and eplrubicin (E) as first-line therapy in patients (PTS) with metastatic breast cancer (MBC)

✍ Scribed by Ch. Thomssen; H.-J. Lück; A. du Bois; B. Lisboa; M. Untch; G. Köhler; D. Hecker; K. Diergarten

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First line therapy with paclitaxel (Taxo

✍ D.A Vorobiof; B.L Rapoport; M.R Chasen; C Slabber; G McMichael; R Eek; C Mohamme 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A multinational phase II study of Navelb

✍ M Untch; S Kahlert; L Petruzelka; M Martin; V Guillem-Porta; M Gil; P Kellokumpu 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Final results of a phase II study ofnab-

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB

446 PUBLICATION A phase II trial of tras

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

PP-7-4 Phase lll study of taxol® (paclit

✍ M.Tubiana Hulin; G. Catimel; J. Bonneterre; J.A. Soares; M. Chazard 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 150 KB

421 POSTER A phase I/II study of capecit

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 505 KB